Chronic PainFibromyalgiaAyahuasca

Long-lasting analgesic effect of the psychedelic drug changa: A case report

This case study (n=1) describes the analgesic effects of repeated changa (unspecified amount of DMT) treatment administered to a 57-year-old male doctor who was suffering for 10 years from chronic fatigue and persistent pain due to fibromyalgia.

Authors

  • Gonzalo Ona

Published

Journal of Psychedelic Studies
individual Study

Abstract

Background and aims: Pain is the most prevalent symptom of a health condition, and it is inappropriately treated in many cases. Here, we present a case report in which we observe a long-lasting analgesic effect produced by changa, a psychedelic drug that contains the psychoactive N,N-dimethyltryptamine and ground seeds of Peganum harmala, which are rich in β-carbolines.

Methods

We describe the case and offer a brief review of supportive findings.

Results

A long-lasting analgesic effect after the use of changa was reported. Possible analgesic mechanisms are discussed. We suggest that both pharmacological and non-pharmacological factors could be involved.

Conclusion

These findings offer preliminary evidence of the analgesic effect of changa, but due to its complex pharmacological actions, involving many neurotransmitter systems, further research is needed in order to establish the specific mechanisms at work.

Available with Blossom Pro

Research Summary of 'Long-lasting analgesic effect of the psychedelic drug changa: A case report'

Introduction

Pain remains a major clinical challenge worldwide, with substantial unmet need for effective, appropriately delivered treatments and concurrent problems such as opioid overuse. The authors situate their report against this background and note that alternative or adjunctive therapies are being explored. Changa is introduced as a smoked psychedelic blend containing freebase N,N-dimethyltryptamine (DMT) together with β-carboline–rich plant material (here, ground Peganum harmala seeds). Its pharmacology and experiential profile are broadly similar to ayahuasca but with much shorter acute duration when smoked (about 15–30 minutes versus 3–5 hours for ayahuasca). The study presents a single-patient case report intended to document an apparent long-lasting analgesic effect after changa use and to consider possible pharmacological and non‑pharmacological mechanisms underlying that effect.

Expert Research Summaries

Go Pro to access AI-powered section-by-section summaries, editorial takes, and the full research toolkit.

Full Text PDF

Full Paper PDF

Create a free account to open full-text PDFs.

Study Details

References (11)

Papers cited by this study that are also in Blossom

A critical review of reports of endogenous psychedelic N, N-dimethyltryptamines in humans: 1955-2010

Barker, S., McIlhenny, E. H., Strassman, R. J. · Drug Testing and Analysis (2012)

Psilocybin-assisted treatment for alcohol dependence: a proof-of-concept study

Bogenschutz, M. P., Forcehimes, A. A., Pommy, J. A. et al. · Journal of Psychopharmacology (2015)

LSD enhances suggestibility in healthy volunteers

Carhart-Harris, R. L., Kaelen, M., Whalley, M. G. et al. · Psychopharmacology (2014)

257 cited
Ketamine for the treatment of addiction: Evidence and potential mechanisms

Ezquerra-Romano, I. I., Lawn, W., Krupitsky, E. M. et al. · Neuropharmacology (2018)

Psilocybin-occasioned mystical experiences in the treatment of tobacco addiction

Garcia-Romeu, A., Griffiths, R. R., Johnson, M. W. · Current Drug Abuse Reviews (2015)

Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effects

Griffiths, R. R., Johnson, M. W., Richards, W. A. et al. · Psychopharmacology (2011)

Psychedelics promote structural and functional neural plasticity

Ly, C., Greb, A. C., Cameron, L. P. et al. · Cell Reports (2018)

New World Tryptamine Hallucinogens and the Neuroscience of Ayahuasca

McKenna, D., Riba, J. · Current Topics in Behavioral Neurosciences (2016)

Neuroendocrine Associations Underlying the Persistent Therapeutic Effects of Classic Serotonergic Psychedelics

Schindler, E. A. D., Wallace, R. M., Sloshower, J. A. et al. · Frontiers in Pharmacology (2018)

Show all 11 references

Cited By (2)

Papers in Blossom that reference this study

Your Personal Research Library

Go Pro to save papers, add notes, rate studies, and organize your research into custom shelves.